XML 58 R47.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue Recognition - Schedule of Revenues from Major Customers (Detail) - Product Concentration Risk [Member] - Revenue Benchmark [Member]
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Largest Customer | HEPLISAV-B        
Concentration Risk [Line Items]        
Percentage of product revenue 27.00% 23.00% 25.00% 20.00%
Second Largest Customer | HEPLISAV-B        
Concentration Risk [Line Items]        
Percentage of product revenue 25.00% 19.00% 24.00% 18.00%
Third Largest Customer | HEPLISAV-B        
Concentration Risk [Line Items]        
Percentage of product revenue 18.00% 18.00% 17.00% 17.00%
Largest Collaboration Partner | CpG 1018        
Concentration Risk [Line Items]        
Percentage of product revenue 0.00% 69.00% 0.00% 46.00%
Second Largest Collaboration Partner | CpG 1018        
Concentration Risk [Line Items]        
Percentage of product revenue 0.00% 22.00% 0.00% 33.00%
Third largest collaboration partner | CpG 1018        
Concentration Risk [Line Items]        
Percentage of product revenue 0.00% 9.00% 0.00% 15.00%